Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1425 of 2873 entries
View as:

Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant

Phase: N/A Priority: Normal
NCT ID: NCT00082706 Org: User:
Start: 04/23/03 End: 12/31/25 Due: 12/31/26

Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT02697227 Org: User:
Start: 08/05/16 End: 12/31/25 Due: 12/31/26

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03026062 Org: User:
Start: 05/18/17 End: 09/30/25 Due: 09/30/26

Gene Expression in Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT03044600 Org: User:
Start: 11/07/12 End: 10/18/17 Due: 10/18/18

Cervical Cancer Screening Study in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT02335372 Org: User:
Start: 06/30/13 End: 10/07/21 Due: 10/07/22

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02455791 Org: User:
Start: 06/24/15 End: 12/31/26 Due: 12/31/27

A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06199466 Org: User:
Start: 01/22/24 End: 01/30/27 Due: 01/30/28

Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT03856515 Org: User:
Start: 06/02/22 End: 08/31/26 Due: 08/31/27

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04516070 Org: User:
Start: 08/28/20 End: 12/31/26 Due: 12/31/27

Use of Nesiritide in the Management of Acute Diastolic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00083772 Org: User:
Start: 05/17/04 End: 04/24/06 Due: 04/24/07

Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT01438476 Org: User:
Start: 01/26/12 End: 10/18/17 Due: 10/18/18

Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry

Phase: N/A Priority: Normal
NCT ID: NCT06840288 Org: User:
Start: 08/31/25 End: 12/31/36 Due: 12/31/37

High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

Phase: N/A Priority: Normal
NCT ID: NCT01266603 Org: User:
Start: 02/22/11 End: 11/01/18 Due: 11/01/19

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

Phase: N/A Priority: Normal
NCT ID: NCT02194387 Org: User:
Start: 09/17/14 End: 09/30/25 Due: 09/30/26

An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04022746 Org: User:
Start: 06/11/19 End: 02/13/25 Due: 02/13/26

Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04746235 Org: User:
Start: 02/22/21 End: 10/31/26 Due: 10/31/27

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00504634 Org: User:
Start: 01/31/04 End: 05/31/10 Due: 05/31/11

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02444741 Org: User:
Start: 09/17/15 End: 09/30/25 Due: 09/30/26

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT02882282 Org: User:
Start: 06/14/17 End: 07/31/25 Due: 07/31/26

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

Phase: N/A Priority: Normal
NCT ID: NCT00283621 Org: User:
Start: 06/02/03 End: 04/12/06 Due: 04/12/07

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03390296 Org: User:
Start: 12/27/17 End: 02/04/22 Due: 02/04/23

Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients

Phase: N/A Priority: Normal
NCT ID: NCT02724956 Org: User:
Start: 11/29/17 End: 12/18/20 Due: 12/18/21

A Pilot Study of Bevacizumab for Neoplastic Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00924820 Org: User:
Start: 06/30/09 End: 09/30/15 Due: 09/30/16

Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT04189770 Org: User:
Start: 02/26/20 End: 02/28/26 Due: 02/28/27

Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03283046 Org: User:
Start: 10/31/17 End: 10/31/20 Due: 10/31/21